AGBL3
Cytosolic carboxypeptidase 3
Also known as: CBPC3_HUMAN, CCP3, MGC32955
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NEM8
- Gene
- AGBL3
- Ensembl
- ENSG00000146856
- Chromosome
- 7
- Canonical length
- 1001 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables metallocarboxypeptidase activity. Involved in protein side chain deglutamylation. Predicted to be located in cytosol. Predicted to be active in centriole and cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1001 residues, UniProt reviewed canonical sequence.
>Q8NEM8|AGBL3
1 MSEDSEKEDY SDRTISDEDE SDEDMFMKFV SEDLHRCALL TADSFGDPFF PRTTQILLEY
61 QLGRWVPRLR EPRDLYGVSS SGPLSPTRWP YHCEVIDEKV QHIDWTPSCP EPVYIPTGLE
121 TEPLYPDSKE ATVVYLAEDA YKEPCFVYSR VGGNRTPLKQ PVDYRDNTLM FEARFESGNL
181 QKVVKVAEYE YQLTVRPDLF TNKHTQWYYF QVTNMRAGIV YRFTIVNFTK PASLYSRGMR
241 PLFYSEKEAK AHHIGWQRIG DQIKYYRNNP GQDGRHYFSL TWTFQFPHNK DTCYFAHCYP
301 YTYTNLQEYL SGINNDPVRS KFCKIRVLCH TLARNMVYIL TITTPLKNSD SRKRKAVILT
361 ARVHPGETNS SWIMKGFLDY ILGNSSDAQL LRDTFVFKVV PMLNPDGVIV GNYRCSLAGR
421 DLNRNYTSLL KESFPSVWYT RNMVHRLMEK REVILYCDLH GHSRKENIFM YGCDGSDRSK
481 TLYLQQRIFP LMLSKNCPDK FSFSACKFNV QKSKEGTGRV VMWKMGIRNS FTMEATFCGS
541 TLGNKRGTHF STKDLESMGY HFCDSLLDYC DPDRTKYYRC LKELEEMERH ITLEKVFEDS
601 DTPVIDITLD VESSSRGSDS SESIDSLTYL LKLTSQKKHL KTKKERNSTI ASHQNARGQE
661 VYDRGHLLQR HTQSNSDVKD TRPNEPDDYM VDYFRRQLPN QGLAHCKLRL PGSRHSPASA
721 SRVAGTTGTR HHTWLIFVFL VEMGKKIPLK GTDLYGNCFK VTSLQSPMGK QTSTWTEKTR
781 IPTEDLHHNL KSKIKECISF QSKKTGINWT DDEKRSYKDK GIVQTQEILQ YLLPIVHSTK
841 NMQTTQIKQL FNPRTNFQIQ HQLNPATCRN IKKYSTSWTA PRNHPFVIQG DVMANSSEWV
901 QSKPHRSLES LSPLKGPKKN KHSQIWAIKN EDIKPLSSKW ETASSSFGMD ANVLKYKSLQ
961 AEETNQQSSK HTALHLTKNK DEQANKNDGQ PTLYLKFQRE SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AGBL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 7.4 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 7.4 nTPM
- testis: 4.7 nTPM
- spleen: 3.5 nTPM
- endometrium: 2.7 nTPM
- thyroid gland: 2.6 nTPM
- salivary gland: 2.4 nTPM
Single-cell type
- cardiomyocytes: 277 nCPM
- late primary spermatocytes: 170 nCPM
- early spermatids: 155 nCPM
- myonuclei: 131 nCPM
- adipocytes: 129 nCPM
- ependymal cells: 120 nCPM
Immune cell
- naive CD8 T-cell: 1.7 nTPM
- memory CD8 T-cell: 0.9 nTPM
- NK-cell: 0.9 nTPM
- gdT-cell: 0.8 nTPM
- memory B-cell: 0.8 nTPM
- MAIT T-cell: 0.7 nTPM
Brain region
- cerebellum: 5.1 nTPM
- hypothalamus: 4.9 nTPM
- white matter: 4.5 nTPM
- cerebral cortex: 4.4 nTPM
- spinal cord: 3.8 nTPM
- basal ganglia: 3.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.92
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AGBL3 as an antibody target. Whether an autoantibody or antibody against AGBL3 could matter depends on whether native AGBL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AGBL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AGBL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...